Detalhe da pesquisa
1.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581940
2.
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397).
Radiother Oncol
; 83(1): 31-41, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17391791
3.
Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines.
Oncol Res
; 14(6): 297-304, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15206492
4.
The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART.
Radiother Oncol
; 111(2): 316-20, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24746580
5.
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 8(6): 475-87, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17482880